SK3 Group Inc. (SKTO)

[I-Glow]

If any of the MMJ companies want to compete in the CBD market they will need to a FDA approved lab.

GW Pharmaceuticals, a drug company that specializes in cannabis-based pharmaceuticals, has received early approval on a patent covering the use of marijuana chemicals for treating brain cancer.

GW Pharmaceuticals announced Wednesday that it has been issued a Notice of Allowance from the U.S. Patent Office for a patent application involving the use of THC and CBD, the two main chemicals in marijuana, for treating gliomas.

It seems there are some companies that are doing things the right way.

Unlike SKTO/AEGY who never do anything that isn't veiled in mystery with unverifiable information in press releases and financial reports.

IG